Prudential Financial’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.11M Buy
84,250
+22,060
+35% +$1.08M 0.01% 1024
2025
Q1
$3.17M Buy
62,190
+56,570
+1,007% +$2.88M ﹤0.01% 1067
2024
Q4
$254K Sell
5,620
-330
-6% -$14.9K ﹤0.01% 2033
2024
Q3
$221K Buy
+5,950
New +$221K ﹤0.01% 2490
2023
Q3
Sell
-5,833
Closed -$244K 2680
2023
Q2
$244K Buy
5,833
+152
+3% +$6.36K ﹤0.01% 2368
2023
Q1
$238K Sell
5,681
-148,100
-96% -$6.2M ﹤0.01% 2343
2022
Q4
$5.87M Sell
153,781
-10,866
-7% -$415K 0.01% 802
2022
Q3
$8.27M Sell
164,647
-22,483
-12% -$1.13M 0.01% 709
2022
Q2
$7.5M Sell
187,130
-12,612
-6% -$505K 0.01% 760
2022
Q1
$7.45M Buy
199,742
+63,729
+47% +$2.38M 0.01% 807
2021
Q4
$5.66M Buy
136,013
+11,659
+9% +$485K 0.01% 958
2021
Q3
$4.63M Buy
124,354
+41,248
+50% +$1.54M 0.01% 1024
2021
Q2
$3.51M Sell
83,106
-144,623
-64% -$6.11M ﹤0.01% 1183
2021
Q1
$10.8M Buy
227,729
+22,846
+11% +$1.08M 0.02% 732
2020
Q4
$12.5M Sell
204,883
-20,470
-9% -$1.25M 0.02% 654
2020
Q3
$10.5M Buy
225,353
+30,960
+16% +$1.45M 0.02% 633
2020
Q2
$9.86M Buy
194,393
+94,615
+95% +$4.8M 0.02% 695
2020
Q1
$4.45M Sell
99,778
-90,989
-48% -$4.06M 0.01% 969
2019
Q4
$9.16M Sell
190,767
-136,052
-42% -$6.53M 0.01% 890
2019
Q3
$11.1M Buy
326,819
+35,139
+12% +$1.19M 0.02% 773
2019
Q2
$13.1M Buy
291,680
+54,069
+23% +$2.43M 0.02% 719
2019
Q1
$8.94M Buy
+237,611
New +$8.94M 0.01% 886
2018
Q4
Sell
-24,280
Closed -$1.14M 2434
2018
Q3
$1.14M Sell
24,280
-59,610
-71% -$2.8M ﹤0.01% 1831
2018
Q2
$2.83M Buy
+83,890
New +$2.83M ﹤0.01% 1477
2017
Q4
Sell
-51,227
Closed -$1.03M 2355
2017
Q3
$1.03M Buy
51,227
+40,212
+365% +$805K ﹤0.01% 1829
2017
Q2
$201K Buy
+11,015
New +$201K ﹤0.01% 2256
2016
Q2
Sell
-108,850
Closed -$701K 2322
2016
Q1
$701K Buy
108,850
+19,300
+22% +$124K ﹤0.01% 1928
2015
Q4
$2.9M Buy
+89,550
New +$2.9M 0.01% 1331